Top compounds associated with response to MYL5


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.05 0.1
mRNA MK-2206 GDSC1000 pan-cancer AAC -0.052 0.2
mRNA Axitinib FIMM pan-cancer AAC 0.22 0.2
mRNA myricetin CTRPv2 pan-cancer AAC 0.054 0.2
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.072 0.2
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA Topotecan CCLE pan-cancer AAC -0.06 0.2
mRNA Topotecan CTRPv2 pan-cancer AAC -0.045 0.2
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC 0.1 0.2
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
Download CSV